Dr. Yi is an immunologist with over 20 years of experience in basic and translational research. He joined Staidson Biopharma in 2019 as director of Biology. Dr. Yi was trained as a medical student and earned his Ph.D. from The Institute for Viral Disease Control and Prevention, Chinese CDC. He then completed his post-doctoral training at the University of North Carolina at Chapel Hill and the University of Iowa. Dr. Yi has developed his industrial expertise in biopharmaceuticals R&D as project leader at various biotech companies, such as NGM Biopharmaceuticals, Abbvie, 23andme, etc. He brings extensive experience in drug discovery especially in Immune Oncology and Autoimmune diseases.